MAP3K7 antibody (full length)
Quick Overview for MAP3K7 antibody (full length) (ABIN306727)
Target
See all MAP3K7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- full length
-
Purpose
- Sheep anti Human TAK1
-
Cross-Reactivity
- Human
-
Characteristics
- C-TAK1 (Cdc25C associated protein kinase) is a ubiquitously expressed protein kinase found in human tissues and cell lines and can phosphorylate Cdc25C on serine 216 in vitro. C-TAK1 is distinct from the DNA damage checkpoint kinase Chk1 and may regulate interactions between Cdc25C and 14-3-3 in vivo by phosphorylating Cdc25C at serine 216.
-
Purification
- Ammonium Sulfate Precipitation
-
Immunogen
- Recombinant, full-length His-tagged human C-TAK1 produced in E. Coli.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Antibody detects c-tak1 by Western blot analysis at 1 to 5 μg/mL. Detects c-tak1 in RKO and HCT116 cell lysates. Optimal concentration should be evaluated by serial dilutions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline with 0.08 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
-
-
- MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7))
-
Alternative Name
- TAK1
-
Background
- Mark3, Sheep anti-Cdc25c associated protein kinase-1, human
-
UniProt
- P27448
-
Pathways
- NF-kappaB Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway
Target
-